Platelet lipidomics: a window of opportunity to assess cardiovascular risk?
Eur Heart J
.
2017 Jul 1;38(25):2006-2008.
doi: 10.1093/eurheartj/ehx258.
Authors
James D McFadyen
1
,
Peter J Meikle
2
,
Karlheinz Peter
1
Affiliations
1
Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.
2
Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.
PMID:
28520938
DOI:
10.1093/eurheartj/ehx258
No abstract available
Publication types
Editorial
Comment
MeSH terms
Blood Platelets
Cardiovascular Diseases*
Coronary Artery Disease*
Humans
Risk Factors